The IL-1 receptor/TLR signaling, cyclooxygenase-2, tumor necrosis factor-alpha, complement signaling, and chemokines are also implicated in epilepsy and could be potential therapeutic targets [281]. The gene discussed is TNF; the disease is epilepsy.